Literature DB >> 15001651

Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.

Hisayo Yokoyama1, Masanori Emoto, Shigehiko Fujiwara, Koka Motoyama, Tomoaki Morioka, Miyoko Komatsu, Hideki Tahara, Hidenori Koyama, Tetsuo Shoji, Masaaki Inaba, Yoshiki Nishizawa.   

Abstract

The purpose of the study was to investigate whether quantitative insulin sensitivity check index (QUICKI) and the reciprocal index of homeostasis model assessment (1/HOMA-IR) are excellent surrogate indexes of insulin resistance in type 2 diabetic patients with various ranges of fasting plasma glucose. One hundred eight type 2 diabetic patients were divided into tertiles according to fasting levels of plasma glucose (FPG) [T1: 4.2 < or = FPG (mmol/liter) < 6.5, n = 36; T2: 6.5 < or = FPG < 8.1, n = 36; T3: 8.1 < or = FPG < or = 11.1, n = 36]. The association between QUICKI or 1/HOMA-IR and insulin resistance index assessed by euglycemic hyperinsulinemic clamp (Clamp-IR) was investigated in each group. QUICKI was strongly correlated with Clamp-IR in all groups (r = 0.615 in T1, r = 0.659 in T2, and r = 0.788 in T3; all subjects, r = 0.691; all P < 0.001). Reciprocal of HOMA-IR also highly correlated with Clamp-IR in all groups (r = 0.600, r = 0.721, and r = 0.730, respectively; all subjects, r = 0.685; all P < 0.001). In conclusion, QUICKI and the reciprocal index of HOMA were highly correlated with Clamp-IR in type 2 diabetic patients with relatively wide ranges of fasting plasma glucose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001651     DOI: 10.1210/jc.2003-031374

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

2.  Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic glucose clamps in rhesus monkeys.

Authors:  Ho-Won Lee; Ranganath Muniyappa; Xu Yan; Lilly Q Yue; Ellen H Linden; Hui Chen; Barbara C Hansen; Michael J Quon
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

3.  Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome.

Authors:  Umer Saleem; Thomas H Mosley; Iftikhar J Kullo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-15       Impact factor: 8.311

4.  Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens.

Authors:  B Charbonnel; M Roden; R Urquhart; S Mariz; D Johns; M Mihm; M Widel; M Tan
Journal:  Diabetologia       Date:  2005-03-01       Impact factor: 10.122

5.  Association between fluoride exposure and cardiometabolic risk in peripubertal Mexican children.

Authors:  Yun Liu; Martha Téllez-Rojo; Brisa N Sánchez; Adrienne S Ettinger; Citlalli Osorio-Yáñez; Maritsa Solano; Howard Hu; Karen E Peterson
Journal:  Environ Int       Date:  2019-11-11       Impact factor: 9.621

6.  Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats.

Authors:  Ranganath Muniyappa; Hui Chen; Radhika H Muzumdar; Francine H Einstein; Xu Yan; Lilly Q Yue; Nir Barzilai; Michael J Quon
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

7.  Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey.

Authors:  Niyati Parekh; Yong Lin; Richard B Hayes; Jeanine B Albu; Grace L Lu-Yao
Journal:  Cancer Causes Control       Date:  2010-01-23       Impact factor: 2.506

8.  Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971-2008).

Authors:  Niyati Parekh; Yong Lin; Maya Vadiveloo; Richard B Hayes; Grace L Lu-Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-24       Impact factor: 4.254

9.  Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.

Authors:  Umer Saleem; Mahyar Khaleghi; Nils G Morgenthaler; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

10.  Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.

Authors:  Dan Niculescu; Mariana Purice; Mihail Coculescu
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.